Global CA Tumor Markers: Growth Opportunities and Strategies
NEW YORK, Dec. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global CA Tumor Markers: Growth Opportunities and Strategies
http://www.reportlinker.com/p0702515/Global-CA-Tumor-Markers-Growth-Opportunities-and-Strategies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 278 pages and 40 tables
CA TUMOR MARKERS: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country
Table of Contents
I. Introduction
II. Worldwide Market and Technology Overview
A. CA Tumor Markers: Clinical Significance
and Laboratory Practices
1. CA 15-3/27.29
2. CA 19-9
3. CA 125
B. Instrumentation Review And
Market Needs
1. Abbott AxSYM
2. Abbott IMx
3. Anagen AN2000/AuraFlex
4. Beckman Coulter Access
5. BioChem Pharma SR1
6. bioMerieux Vidas Series
7. Biotrol Systems 7000
8. J&J Diagnostics/Amersham Amerlite
9. J&J Diagnostics Vitros ECI
10. Olympus PK Series
11. Roche Cobas Core
12. Roche Elecsys
13. Roche ES 22
14. Roche ES 33
15. Roche ES 300/300 AL
16. Siemens ACS: 180
17. Siemens ACS: Centaur
18. Siemens ELISA Processor II/III
19. Siemens Immuno 1
20. Siemens/Opus/Plus/Magnum
21. Siemens Stratus
22. Tosoh AIA Series
23. Wallac/Pharmacia Delfia
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays a. Technological Principle
b. Radioimmunoassay (RIA)
Table of Contents (continued)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
6. Microcomputers and Automation
7. Artificial Intelligence 8. Flow Cytometry
9. Biosensors
D. Competing/Complementing Technologies
1. CT
Table of Contents (continued)
2. MRI
3. NMR
4. PET
5.Photonics Spectroscopy
E. Personal Testing
III. France: Market Size, Growth and Major Suppliers' Sales
and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment
VI. Japan: Market Size, Growth and Major Suppliers' Sales
and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers' Sales
and Market Shares
VIII. U.K.: Test Volume and Diagnostics Sales Forecast
by Market Segment
IX. U.S.A.: Market Size, Growth and Major Suppliers' Sales
and Market Shares
X. Design Criteria for Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
Table of Contents (continued)
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. Competitive Profiles
- Abbott
- AdnaGen
- Ambrilia Biopharma
- AMDL
- Beckman Coulter
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CanAG Diagnostics
- CeMines
- Cepheid
- Correlogic Systems
- Dako
- Decode
- Diadexus - Diagnocure
- Diasorin
- Eiken Chemical
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
Table of Contents (continued)
- Gen-Probe
- Guided Therapeutics
- Hologic
- Ipsogen
- J&J Diagnostics
- Kreatech
- Kyowa Medex
- Mackay Life Sciences
- Matritech
- Myriad Genetics
- OncoLab
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac
- Zila
CA TUMOR MARKERS: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country
List of Tables
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
France
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
France
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
France
CA 125 Test Volume and Diagnostics Sales by Market
Segment
France
CA 15-3/27.29 Testing Market by Major Supplier
France
CA 19-9 Testing Market by Major Supplier
France
CA 125 Testing Market by Major Supplier
Germany
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
Germany
CA 19-9 Test Volume and Diagnostics Sales by Market
SegmentList of Tables (continued)
Germany
CA 125 Test Volume and Diagnostics Sales by Market
Segment
Germany
CA 15-3/27.29 Testing Market by Major Supplier
Germany
CA 19-9 Testing Market by Major Supplier
Germany
CA 125 Testing Market by Major Supplier
Italy
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
Italy
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
Italy
CA 125 Test Volume and Diagnostics Sales by Market
Segment
Japan
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
Japan
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
Japan
CA 125 Test Volume and Diagnostics Sales by Market
Segment
Japan
CA 15-3/27.29 Testing Market by Major Supplier List of Tables (continued)
Japan
CA 19-9 Testing Market by Major Supplier
Japan
CA 125 Testing Market by Major Supplier
Spain
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
Spain
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
Spain
CA 125 Test Volume and Diagnostics Sales by Market
Segment
Spain
CA 15-3/27.29 Testing Market by Major Supplier
Spain
CA 19-9 Testing Market by Major Supplier
Spain
CA 125 Testing Market by Major Supplier
U.K.
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
U.K.
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
U.K.
CA 125 Test Volume and Diagnostics Sales by Market
SegmentList of Tables (continued)
U.S.A.
CA 15-3/27.29 Test Volume and Diagnostics Sales by Market
Segment
U.S.A.
CA 19-9 Test Volume and Diagnostics Sales by Market
Segment
U.S.A.
CA 125 Test Volume and Diagnostics Sales by Market
Segment
U.S.A.
CA 15-3/27.29 Testing Market by Major Supplier
U.S.A.
CA 19-9 Testing Market by Major Supplier
U.S.A.
CA 125 Testing Market by Major Supplier
To order this report:
Diagnostics Industry: Global CA Tumor Markers: Growth Opportunities and Strategies
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article